Peter G. Milner
47Patents
12h-index
28Co-inventors
81Inventor score
Filing activity: Jun 21, 1990 → Aug 12, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6849714B1 | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components | Emerging Cross-Sectional Technologies | 164 | Expired |
| US6887470B1 | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components | Chemistry; Metallurgy | 134 | Expired |
| US7256253B2 | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components | Chemistry; Metallurgy | 76 | Expired |
| US6706892B1 | Pulmonary delivery for bioconjugation | Human Necessities | 72 | Expired |
| US7601691B2 | Anti-obesity agents | Chemistry; Metallurgy | 23 | Expired |
| US6552046B2 | Materials and methods for the treatment of gastroesophageal reflux disease | Chemistry; Metallurgy | 23 | Expired |
| US5668139A | A1 adenosine receptor agonists and antagonists | Chemistry; Metallurgy | 22 | Expired |
| US6087375A | Methods of treating or preventing thromboses | Human Necessities | 19 | Expired |
| US6500918B2 | Conjugate comprising an antinociceptive agent covalently bonded to a blood component | Chemistry; Metallurgy | 18 | Expired |
| US6437092B1 | Conjugates of opioids and endogenous carriers | Chemistry; Metallurgy | 15 | Expired |
| US5631260A | Xanthine epoxides as A.sub.1 adenosine receptor agonists and antagonists | Chemistry; Metallurgy | 14 | Expired |
| US9549912B2 | Methods for treating atrial fibrillation | Human Necessities | 13 | Active |
| US7090851B1 | Long lasting fusion peptide inhibitors of viral infection | Chemistry; Metallurgy | 12 | Expired |
| US6680387B2 | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis | Chemistry; Metallurgy | 11 | Expired |
| US6602981B2 | Antinociceptive agent derivative | Chemistry; Metallurgy | 10 | Expired |
| US6610825B2 | Method for alleviating pain or providing an analgesic effect in a patient | Chemistry; Metallurgy | 10 | Expired |
| US6372783B1 | Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use | Human Necessities | 9 | Expired |
| US6362223B1 | Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use | Human Necessities | 9 | Expired |
| US6316487A | Compounds for treatment of cardiac arrhythmia synthesis, and methods of use | Human Necessities | 8 | Expired |
| US6114344A | Long-acting local anesthetics | Human Necessities | 8 | Expired |
| US6683086B2 | Ultrashort acting hypnotic barbiturates | Chemistry; Metallurgy | 7 | Expired |
| US5998387A | Method for using A.sub.1 adenosine receptor agonists | Chemistry; Metallurgy | 6 | Expired |
| US5736528A | N.sup.6 -(epoxynorborn-2-yl) adenosines as A.sub.1 adenosine receptor agonists | Chemistry; Metallurgy | 5 | Expired |
| US7608271B2 | Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing group | Chemistry; Metallurgy | 5 | Expired |
| US7582301B1 | Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptides | Chemistry; Metallurgy | 5 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.